Search research articles
Contact Us
Filters
Showing results (101-110 of 134) with videos related to
Page
of 14
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 28, 2014
A phase 1 trial of oncolytic HSV-1, G207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responses
James M Markert, Shantanu N Razdan, Hui-Chien Kuo, et al.
Neuro-Oncology
|
July 6, 2019
The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients
Craig Horbinski, Keith L Ligon, Priscilla Brastianos, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 29, 2004
A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting
E Antonio Chiocca, Khalid M Abbed, Stephen Tatter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 14, 2013
Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma
Tracy T Batchelor, Paul Mulholland, Bart Neyns, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2024
Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT
Manmeet S Ahluwalia, Ahmad Ozair, Jan Drappatz, et al.
JCO Precision Oncology
|
September 11, 2020
Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With Glioblastoma
Brian M Alexander, Lorenzo Trippa, Sarah Gaffey, et al.
Neuro-Oncology
|
March 12, 2026
Evaluating "Brain Permeability": A Critical Issue for the Development of Therapeutic Agents for Primary and Metastatic Brain Tumors
Stuart A Grossman, Amy Barone, Roy E Strowd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2021
Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement
Stephen J Bagley, Shawn Kothari, Rifaquat Rahman, et al.
JAMA Oncology
|
December 26, 2024
Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors: A Review
Craig Horbinski, David A Solomon, Rimas V Lukas, et al.
Cancer Research
|
March 14, 2018
Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma
Hirokazu Sadahiro, Kyung-Don Kang, Justin T Gibson, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 134) with videos related to
Sort By:
Page
of 14
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 28, 2014
A phase 1 trial of oncolytic HSV-1, G207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responses
James M Markert, Shantanu N Razdan, Hui-Chien Kuo, et al.
Neuro-Oncology
|
July 6, 2019
The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients
Craig Horbinski, Keith L Ligon, Priscilla Brastianos, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 29, 2004
A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting
E Antonio Chiocca, Khalid M Abbed, Stephen Tatter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 14, 2013
Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma
Tracy T Batchelor, Paul Mulholland, Bart Neyns, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2024
Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT
Manmeet S Ahluwalia, Ahmad Ozair, Jan Drappatz, et al.
JCO Precision Oncology
|
September 11, 2020
Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With Glioblastoma
Brian M Alexander, Lorenzo Trippa, Sarah Gaffey, et al.
Neuro-Oncology
|
March 12, 2026
Evaluating "Brain Permeability": A Critical Issue for the Development of Therapeutic Agents for Primary and Metastatic Brain Tumors
Stuart A Grossman, Amy Barone, Roy E Strowd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2021
Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement
Stephen J Bagley, Shawn Kothari, Rifaquat Rahman, et al.
JAMA Oncology
|
December 26, 2024
Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors: A Review
Craig Horbinski, David A Solomon, Rimas V Lukas, et al.
Cancer Research
|
March 14, 2018
Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma
Hirokazu Sadahiro, Kyung-Don Kang, Justin T Gibson, et al.
Page
of 14